SAMSUNG BIOEPIS NL B.V.

This medicine is used for the treatment of several types of advanced-stage cancer in adults, including colorectal cancer (colon or rectum), metastatic breast cancer, non-small cell lung cancer, kidney cancer, primary ovarian, Fallopian tube, or peritoneal cancer, and cervical cancer.

Dosage form: solution for infusion, concentrate

ATC: L01FG01

This medicine is used to reduce inflammation associated with certain diseases, such as rheumatoid arthritis (moderate to severe), psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), and plaque psoriasis (moderate to severe). It is also used in children and adolescents for specific forms of arthritis and psoriasis, provided they weigh 62.5 kg or more.

Dosage form: solution for injection

ATC: L04AB01

It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).

Dosage form: solution for injection

ATC: S01LA04

The drug is used to treat adults and children suffering from paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two diseases that affect the blood and can damage red blood cells, kidneys, muscles, or nerves.

Dosage form: solution for infusion, concentrate

ATC: L04AJ01

It is used in adults to treat inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), and psoriasis. It is also indicated for adults and children aged 6 years and older for Crohn's disease and ulcerative colitis.

Dosage form: powder for concentrate for infusion solution

ATC: L04AB02

Imraldi is a medicine that acts on the immune system and is indicated for the treatment of several inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, non-infectious uveitis, ankylosing spondylitis, and other forms of arthritis.

Dosage form: solution for injection

ATC: L04AB04

Obodence is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss related to long-term glucocorticoid use in patients at risk of fracture.

Dosage form: solution for injection in pre-filled syringe

ATC: M05BX04

Ontruzant is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, provided that the tumor cells show high levels of a protein called HER2.

Dosage form: powder for concentrate for infusion solution

ATC: L01FD01

Opuviz is used in adults to treat several eye diseases, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV).

Dosage form: solution for injection

ATC: S01LA05

Pyzchiva is used for the treatment of certain inflammatory diseases, including plaque psoriasis, psoriatic arthritis, and Crohn's disease (moderate to severe).

Dosage form: solution for injection in pre-filled syringe

ATC: L04AC05

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or pressure on the bone marrow) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Dosage form: solution for injection

ATC: M05BX04